Literature DB >> 22744268

Hypersensitivity reactions to proton pump inhibitors.

Yoon-Seok Chang1.   

Abstract

PURPOSE OF REVIEW: Proton pump inhibitors (PPI) are one of most frequently prescribed drugs in the world. The purpose of this review is to describe the hypersensitivity reactions to PPI. RECENT
FINDINGS: Hypersensitivity reactions to PPI vary from mild symptoms to life-threatening disorders. Cases of urticaria, angioedema, anaphylaxis, cytopenia, vasculitis, acute allergic interstitial nephritis, occupational contact dermatitis, photoallergic dermatitis, maculopapular eruption, erythroderma, Drug rash with eosinophilia and systemic symptoms (DRESS) syndrome, Stevens-Johnson syndrome/toxic epidermal necrolysis, and other autoimmune reactions (including cutaneous lupus erythematosus) have been described.
SUMMARY: A high level of clinical suspicion is critical in the diagnosis of PPI-induced hypersensitivity reactions. Physicians should be aware of the possible hypersensitivity reactions due to PPI and routine/empirical prescription for PPI should only be used when clinically indicated.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22744268     DOI: 10.1097/ACI.0b013e328355b8d3

Source DB:  PubMed          Journal:  Curr Opin Allergy Clin Immunol        ISSN: 1473-6322


  10 in total

1.  Hypersensitivity reaction to omeprazole in a patient treated for Helicobacter pylori.

Authors:  Sarah Anderson; Sarah Christensen
Journal:  Therap Adv Gastroenterol       Date:  2015-03       Impact factor: 4.409

2.  Lansoprazole-Induced Subacute Cutaneous Lupus Erythematosus.

Authors:  İsa An; Vasfiye Demir; İbrahim Ibiloğlu; Sedat Akdeniz; Derya Uçmak
Journal:  Arch Rheumatol       Date:  2017-03-21       Impact factor: 1.472

3.  Analysis of cytopenia in geriatric inpatients.

Authors:  G Röhrig; I Becker; K Pappas; M C Polidori; R J Schulz
Journal:  Z Gerontol Geriatr       Date:  2017-06-28       Impact factor: 1.281

4.  Proton pump inhibitor-induced exfoliative dermatitis: A case report.

Authors:  Zhihong Qiu; Hongtao Liu; Lien He; Yinling Ma; Haojing Song; Wanjun Bai; Meiling Yu
Journal:  Exp Ther Med       Date:  2015-12-08       Impact factor: 2.447

5.  Update on Epidemiology and Clinical Assessment Tools of Cutaneous Lupus Erythematosus and Dermatomyositis.

Authors:  Yunyoung C Chang; Victoria P Werth
Journal:  Curr Dermatol Rep       Date:  2013-01-24

Review 6.  Eosinophilic Drug Allergy.

Authors:  Merin Kuruvilla; David A Khan
Journal:  Clin Rev Allergy Immunol       Date:  2016-04       Impact factor: 10.817

7.  Toxic epidermal necrolysis induced by Lansoprazole: pharmacologic considerations.

Authors:  Ciro Martins Gomes
Journal:  An Bras Dermatol       Date:  2013 May-Jun       Impact factor: 1.896

8.  IgE-mediated allergy to proton pump inhibitors with both delayed and immediate onset.

Authors:  Leyla Barakat; Maria João Vasconcelos; Jean Luc Bourrain; Pascal Demoly; Anca-Mirela Chiriac
Journal:  Asia Pac Allergy       Date:  2019-10-14

9.  Proton Pump Inhibitor Induced Subacute Cutaneous Lupus Erythematosus: A Case Series of 7 Patients and Brief Review of Literature.

Authors:  Sukhjot Kaur; Palvi Singla; Sandeep Kaur; Amit Kansal; Aditi Bansal; Aminder Singh
Journal:  Indian Dermatol Online J       Date:  2022-01-24

10.  Proton pump inhibitor-induced subacute cutaneous lupus erythematosus.

Authors:  L H Sandholdt; R Laurinaviciene; A Bygum
Journal:  Br J Dermatol       Date:  2014-02       Impact factor: 9.302

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.